Back

P372
Heparin binding copolymer reverses the anticoagulant activity of low molecular weight heparins: safety and efficacy data in rats

Cardiovascular Research

23 April 2018
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Session
Antithrombotic therapy for critically ill patients: focusing on anticoagulants
26 March 2023
thumbnail
Congress Presentation
Effectiveness and safety of half-dose thrombolysis in intermediate-high risk pulmonary embolism: a single centre experience
9 March 2024
thumbnail
Congress Presentation
Anti-Xa/APTT discrepancy in heparinized ImpellaTM-supported cardiogenic shock patients can predict mortality
9 March 2024
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources